MLNIX
Price
$28.45
Change
-$0.31 (-1.08%)
Updated
Jul 13 closing price
Net Assets
435.32M
RNPCX
Price
$71.64
Change
-$0.96 (-1.32%)
Updated
Jul 13 closing price
Net Assets
170.23B
Interact to see
Advertisement

MLNIX vs RNPCX

MLNIX vs RNPCX Comparison Chart in %
View a ticker or compare two or three
VS
MLNIX vs. RNPCX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLNIX is a Hold and RNPCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNPCX has more cash in the bank: 170B vs. MLNIX (435M). RNPCX pays higher dividends than MLNIX: RNPCX (0.70) vs MLNIX (0.05). MLNIX was incepted earlier than RNPCX: MLNIX (10 years) vs RNPCX (24 years). MLNIX (1.05) and RNPCX (1.05) have similar cost to investors . MLNIX is a more actively managed with annual turnover of: 51.00 vs. RNPCX (23.00). RNPCX has a lower initial minimum investment than MLNIX: RNPCX (250) vs MLNIX (1000000). MLNIX annual gain was more profitable for investors over the last year : 10.59 vs. RNPCX (6.93). MLNIX return over 5 years is better than : 51.23 vs. RNPCX (11.29).
MLNIXRNPCXMLNIX / RNPCX
Total Expense Ratio1.001.0595%
Annual Report Gross Expense Ratio1.051.05100%
Fund Existence10 years24 years-
Gain YTD6.3225.152123%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets435M170B0%
Annual Yield % from dividends0.050.707%
Returns for 1 year10.596.93153%
Returns for 3 years67.5932.65207%
Returns for 5 years51.2311.29454%
Returns for 10 years194.61103.71188%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HIEMX7.77N/A
N/A
Virtus SGA Emerging Markets Equity I
VESIX47.21N/A
N/A
Vanguard European Stock Instl
FSGAX48.69N/A
N/A
Franklin Small-Mid Cap Growth Adv
FBTDX177.71N/A
N/A
Franklin Biotechnology Discovery C
TSLTX6.45N/A
N/A
Transamerica Small Cap Value I3